Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.95
-0.14 (-0.99%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Avanos Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6495227321,0361,2591,671
Market Cap Growth
-4.84%-28.70%-29.35%-17.74%-24.66%-23.98%
Enterprise Value
688.08542.61773.931,1361,3901,726
Last Close Price
13.9511.2315.9222.4327.0634.67
PE Ratio
--7.15-1.87-16.9925.29-54.17
Forward PE
13.9511.7010.1015.6515.8923.16
PEG Ratio
-4.394.392.340.891.30
PS Ratio
0.930.741.061.541.842.85
PB Ratio
0.830.670.880.840.981.32
P/TBV Ratio
0.830.670.880.850.991.33
P/FCF Ratio
15.0512.108.8370.9417.5825.21
P/OCF Ratio
8.696.987.2731.9713.8519.14
EV/Sales Ratio
0.980.771.131.692.032.94
EV/EBITDA Ratio
12.65-23.90-2.2122.5816.71-2465.15
EV/EBIT Ratio
44.39-8.81-1.95270.4039.16-44.25
EV/FCF Ratio
15.9612.599.3477.7919.4226.03
Debt / Equity Ratio
0.140.140.180.150.200.14
Debt / EBITDA Ratio
-5.69-5.69-0.484.163.33-267.86
Debt / FCF Ratio
3.003.002.0514.323.872.83
Net Debt / Equity Ratio
0.050.050.080.100.120.05
Net Debt / EBITDA Ratio
-1.73-1.73-0.182.411.79-98.57
Net Debt / FCF Ratio
0.910.910.758.322.091.04
Asset Turnover
0.630.630.480.390.400.36
Inventory Turnover
2.422.422.031.991.991.75
Quick Ratio
1.171.171.450.981.551.79
Current Ratio
2.152.152.372.083.273.07
Return on Equity (ROE)
-9.07%-9.07%-37.42%-0.78%1.68%-2.45%
Return on Assets (ROA)
-5.88%-6.09%-26.66%0.30%1.69%-1.75%
Return on Invested Capital (ROIC)
-7.54%-7.81%-32.21%0.36%2.00%-2.07%
Return on Capital Employed (ROCE)
-6.50%-6.50%-32.39%0.28%2.32%-2.63%
Earnings Yield
-11.24%-13.98%-53.58%-5.88%3.95%-1.85%
FCF Yield
6.64%8.26%11.33%1.41%5.69%3.97%
Buyback Yield / Dilution
-0.65%-0.65%1.29%1.48%2.67%-1.67%
Total Shareholder Return
-0.65%-0.65%1.29%1.48%2.67%-1.67%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q